Morningstar

Virtus LifeSci Biotech Products ETF BBP

Morningstar Medalist Rating
Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBP

Will BBP outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable BBP’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the BBP management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of BBP’s parent organization’s priorities and whether they’re in line with investors’ interests.

The combination of a middling Process Pillar rating and a Below Average People Pillar rating limit Virtus LifeSci Biotech Products ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBP

More BBP Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 22.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Travere Therapeutics Inc Ordinary Shares

2.87 630,946
Healthcare

ADMA Biologics Inc

2.71 595,764
Healthcare

Alnylam Pharmaceuticals Inc

2.54 558,850
Healthcare

Mirum Pharmaceuticals Inc

2.33 512,153
Healthcare

Phathom Pharmaceuticals Inc Ordinary shares

2.29 504,107
Healthcare

BeiGene Ltd ADR

2.10 462,294
Healthcare

TG Therapeutics Inc

2.00 439,789
Healthcare

Gilead Sciences Inc

2.00 439,123
Healthcare

Aurinia Pharmaceuticals Inc

1.99 438,314
Healthcare

Kiniksa Pharmaceuticals International PLC Class A

1.96 430,649
Healthcare

Sponsor Center